BackSharps Technology Overview
Sharps Technology Inc

Sharps Technology Return on Equity

Latest ROE for Sharps Technology: -85.94% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-85.94%

Return on Equity

-85.94%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Sharps Technology (STSS) FAQ

Sharps Technology (STSS) currently reports a ROE of -85.94%. That is below the Healthcare sector average of 13.1%. Use the charts on this page to explore Sharps Technology's ROE history and peer comparisons.

Sharps Technology's ROE of -85.94% is lower than the Healthcare sector average of 13.1%. That is roughly 755.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Sharps Technology's current -85.94% should be judged against Healthcare norms (sector average: 13.1%) and against STSS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -85.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.1%. From there, open related valuation or income-statement pages for Sharps Technology, and consider following STSS for alerts when major investors trade the stock.

Sharps Technology is classified in the Healthcare sector. On ROE, it currently shows -85.94% versus a sector average near 13.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STSS with unrelated industries.